Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost‐utility analysis

2012126 citationsJournal Articlegreen Open Access

Authors

Matthew R. Cooperberg · UCSF Helen Diller Family Comprehensive Cancer Center

Naren Ramakrishna · Orlando Health

Steven B. Duff · Bureau Veritas (France)

Kathleen E. Hughes · Prevea Health

Sara Sadownik · Prevea Health

Joseph A. Smith · Vanderbilt University

Ashutosh Tewari ·

Abstract

Our analysis found small differences in outcomes and substantial differences in payer and patient costs across treatment alternatives. These findings may inform future policy discussions about strategies to improve efficiency of treatment selection for localised prostate cancer.

Topics & Keywords

Prostate Cancer Diagnosis and Treatment Prostate Cancer Treatment and Research Statistical Methods in Clinical Trials

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: British Journal of Urology

Volume 111, Issue 3, pp. 437-450

DOI: 10.1111/j.1464-410x.2012.11597.x

Field-Weighted Citation Impact: 8.82